Genotypes and prevalence of HPV single and multiple concurrent infections in women with HSIL

Diagnostic Cytopathology

Volumn 42, Issue 11, 2014, Pages 919-923

  Beca, Francisco ^a,b,c   Pinheiro, Jorge ^b,c   Rios, Elisabete ^a,b,c   Pontes, Patricia ^c   Amendoeira, Isabel ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c Centro Hospitalar Universitário de São João   (Portugal)

Author keywords

Genotyping; Gynaecological cytology; HPV

Indexed keywords

ADULT; ARTICLE; CONCURRENT INFECTION; CROSS-SECTIONAL STUDY; CYTODIAGNOSIS; FEMALE; GENOTYPE; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 43; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 82; LOW RISK PATIENT; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS; COINFECTION; GENETICS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; VIROLOGY;

ADULT; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX;

EID: 84912575428     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.23143     Document Type: Article

References (17)

1. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97:1072-1079.
2. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915-1927.
3. Paavonen J, Naud P, Salmeron J, et al.; HPV PATRICIA Study Group Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a doubleblind, randomized study in young women. Lancet 2009;374:301-314.
4. Castellsague X, Iftner T, Roura E, et al.; CLEOPATRE Spain Study Group Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: The CLEOPATRE study. J Med Virol 2012;84:947-956.
5. Carozzi F, Ronco G, Gillio-Tos A, et al.; New Technologies for Cervical Cancer screening (NTCC) Working Group. Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study. Eur J Cancer 2012;48:1633-1637.
6. Wheeler CM, Hunt WC, Cuzick J, et al.; New Mexico HPV Pap Registry Steering Committee. A population-based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination. Int J Cancer 2013;132:198-207.
7. Vaccarella S, Franceschi S, Snijders PJ, Herrero R, Meijer CJ, Plummer M; IARC HPV Prevalence Surveys Study Group. Concurrent infection with multiple human papillomavirus types: Pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2010;19:503-10.
8. Solomon D, Davey D, Kurman R, et al.; Forum Group Members; Bethesda 2001 Workshop The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119.
9. Wang S, Wei H, Wang N, et al. The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China. BMC Cancer 2012;12:160.
10. Hariri S, Unger ER, Sternberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006. J Infect Dis 2011;204:566-573.
11. Dunne EF, Sternberg M, Markowitz LE, et al. Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States-National Health And Nutrition Examination Survey, 2003-2006: Opportunity to measure HPV vaccine impact? J Infect Dis 2011;204:562-565.
12. Van Der Marel J, Quint WG, Schiffman M, et al. Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. Int J Cancer 2012;131:E946-E953.
13. Hariri S, Steinau M, Rinas A, et al. HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006. PLoS One 2012;7:e34044.
14. De Sanjose S, Quint WG, Alemany L, et al.; Retrospective International Survey and HPV Time Trends Study Group Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 2010;11:1048-1056.
15. Alemany L, De Sanjose S, Tous S, et al.; on Behalf of the RIS HPV TT Study Group Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007. Int J Cancer (in press).
16. Berois N, Heard I, Fort Z, et al. Prevalence of type-specific HPV infection in Uruguay. J Med Virol 2014;86:647-652.
17. De Oliveira CM, Fregnani JH, Carvalho JP, Longatto-Filho A, Levi JE. Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil. BMC Cancer 2013;13:357.